Paid Clinical Trials Boulder
Discover 1,557 paid clinical trials in Boulder, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)
Sponsor:
Boston Children's Hospital
Location:
Code:
NCT05600426
Conditions
Severe Aplastic Anemia
Eligibility Criteria
Sex: All
Age: 0 - 25
Healthy Volunteers: Not accepted
Interventions
cyclosporine
Matched Unrelated Donor Hematopoetic Stem Cell Transplant
horse anti-thymocyte globulin (ATG)
rabbit anti-thymocyte globulin (ATG)
Methotrexate
First in Human Study of TORL-3-600 in Participants With Advanced CancerFirst in Human Study of TORL-3-600 in Participants With Advanced Cancer
Sponsor:
TORL Biotherapeutics, LLC
Location:
Code:
NCT05948826
Conditions
Advanced Solid Tumor
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TORL-3-600
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
Sponsor:
University of Colorado, Denver
Location:
Code:
NCT05935826
Conditions
Hepatic Steatosis
NAFLD
Adolescent Obesity
Eligibility Criteria
Sex: All
Age: 13 - 18
Healthy Volunteers: Not accepted
Interventions
Essential Amino Acid Supplement by Amino Co
Placebo
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)
Sponsor:
UCB Biopharma SRL
Location:
Code:
NCT05063162
Conditions
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Rozanolixizumab
Placebo
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid ArthritisA Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis
Sponsor:
Immunovant Sciences GmbH
Location:
Code:
NCT06754462
Conditions
Rheumatoid Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
IMVT-1402
Placebo
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Sponsor:
Pfizer
Location:
Code:
NCT06447662
Conditions
Carcinoma, Pancreatic Ductal
Colorectal Neoplasms
Carcinoma, Non-Small-Cell Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PF-07934040
Gemcitabine
Nab-paclitaxel
Cetuximab
Fluorouracil
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in WomenUnderstanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women
Sponsor:
University of Colorado, Denver
Location:
Code:
NCT06441474
Conditions
Breast Cancer Female
Eligibility Criteria
Sex: Female
Age: 39 - 49
Healthy Volunteers: Not accepted
Cognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean DeliveriesCognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean Deliveries
Sponsor:
University of Colorado, Denver
Location:
Code:
NCT04203082
Conditions
Procedural Anxiety
High Risk Pregnancy
Fetal Complications
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Exposure Intervention
Usual Care
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight InfantsPercutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants
Sponsor:
Nationwide Children's Hospital
Location:
Code:
NCT05547165
Conditions
Ductus Arteriosus, Patent
Eligibility Criteria
Sex: All
Age: 7 - 32
Healthy Volunteers: Not accepted
Interventions
Percutaneous Patent Ductus Arteriosus Closure (PPC)
Responsive Management Intervention
Echocardiogram, cardiac
A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Sponsor:
Nuvalent Inc.
Location:
Code:
NCT05118789
Conditions
Locally Advanced Solid Tumor
Metastatic Solid Tumor
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
NVL-520